At 12.3% CAGR, the Middle East & Africa Colorectal Procedure Market is Projected to be Worth US$ 806.74 million by 2028, says Business Market Insights

According to Business Market Insights research, the Middle East & Africa colorectal procedure market was valued at US$ 402.33 million in 2022 and is expected to reach US$ 806.74 million by 2028, registering a CAGR of 12.3% from 2022 to 2028. Increasing prevalence of colorectal cancer and new product launches are the factors attributed to the Middle East & Africa colorectal procedure market expansion.

The colorectal procedural market players focus on launching new products to expand their countries reach and enhance capacities to cater to a greater than existing customer base. In August 2021, Ethicon announced the echelon circular Powered Stapler results. The product helped in 74% reduction in the anastomotic leak and a 44% reduction in 30-day inpatient hospital readmission rates after colorectal surgery compared to the manual circular staplers. The GI genius is the first and the only commercially available computer-aided detection (CADe) system using artificial intelligence (AI) to identify colorectal polyps. The module, compatible with any colonoscope video, provides physicians with a powerful new solution to fight against colorectal cancer. Likewise, in April 2022, Safeheal announced the first patient enrollment in its pivotal study of Colovac, a groundbreaking endoluminal bypass sheath. Colovac is an alternative to temporary diverting ostomy for patients undergoing colorectal resection. Similarly, Medicare, the popular government insurance program, provides cover for PAP tests, pelvic exams, and clinical colon examinations for colorectal cancer screening every two years. Such programs and developments and launch of new products are likely to bring new trends in the colorectal procedural test market in the coming years, thereby supporting its growth.

On the contrary, complications associated with colorectal procedure systems hampers the Middle East & Africa colorectal procedure market.  

Based on product, the Middle East & Africa colorectal procedure market is segmented into endoscope, electrosurgery, handheld devices and visual systems, sealing and stapling devices, ligation clips and dilators and speculas, cutter and shears, accessories, and others. The endoscope segment held 38.8% share of Middle East & Africa colorectal procedure market in 2022, amassing US$ 156.17 million. It is projected to garner US$ 309.74 million by 2028 to expand at 12.1% CAGR during 2022–2028. 

Based on surgery, the Middle East & Africa colorectal procedure market is segmented into right hemicolectomy, left hemicolectomy, subtotal colectomy, low anterior resection, abdomino-perineal resection, and others (including endoscopic surgery). The subtotal colectomy segment held 64.0% share of Middle East & Africa colorectal procedure market in 2022, amassing US$ 257.69 million. It is projected to garner US$ 519.56 million by 2028 to expand at 12.4% CAGR during 2022–2028.

Based on end user, the Middle East & Africa colorectal procedure market is segmented into hospitals & clinics, surgery centers, and others. The hospitals and clinics segment held 58.4% share of Middle East & Africa colorectal procedure market in 2022, amassing US$ 235.11 million. It is projected to garner US$ 466.28 million by 2028 to expand at 12.1% CAGR during 2022–2028.

Based on indication, the Middle East & Africa colorectal procedure market is segmented into colon polyps, Crohn's disease, colorectal cancer, colitis, irritable bowel syndrome, and other indications. The irritable bowel syndrome segment held 44.0% share of Middle East & Africa colorectal procedure market in 2022, amassing US$ 176.94 million. It is projected to garner US$ 364.49 million by 2028 to expand at 12.8% CAGR during 2022–2028.

Based on country, the Middle East & Africa colorectal procedure market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that the Saudi Arabia captured 34.0% share of Middle East & Africa colorectal procedure market in 2022. It was assessed at US$ 136.59 million in 2022 and is likely to hit US$ 269.05 million by 2028, exhibiting a CAGR of 12.0% during 2022–2028.      

Key players operating in the Middle East & Africa colorectal procedure market are Ethicon (Johnson & Johnson Services, Inc.); Medtronic; B. Braun Melsungen AG; Cardinal Health Inc; Boston Scientific Corporation; CooperSurgical, Inc; and Olympus Corporation, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com